The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
The EPITA Board is proud to announce the 10th EPITA Symposium & 39th AIDPIT Workshop, which will take place in Igls_Innsbruck from the 26th to the 28th of January 2020.
This EPITA anniversary meeting will be characterized and enriched by a series of new, additional sessions dedicated on the use of pluripotent stem cells in clinical beta cell therapy in collaboration with ECTORS (European Cell Therapy and Organ Regeneration Section).
The first trials using stem-cell derived β-cells in patients with type 1 diabetes are underway. As a community with exceptional expertise in the field of pancreas and islet transplantation, immunosuppression and monitoring of graft function the time is right to have a special focus on the “Road to the Clinic” for this novel therapy, in and outside Europe.
Topics will include differentiation protocols, upscaling to bioreactors, quality control, pre-clinical testing, safety aspects, manufacturing and regulatory issues in Europe. Especially current hurdles will be discussed.
These additional, focused sessions will be held on Sunday, January 26. On Monday morning, January 27, a series of sessions that are relevant to to all scientists and clinicians involved in pancreas, islet and stem-cell derived β-cell transplantation, including topics such as immunological aspects, alternative transplantation sites and graft monitoring. In this way the meeting structure, lively atmosphere and scientific discussions on pancreas and islet transplantation will be preserved, while also moving into the future with novel cell replacement therapies.
Including Pre-symposium Activity on January 26 and morning of January 27, 2020
Stem-cell derived β-cells: THE ROAD TO THE CLINIC
The new sessions have been included:
– To inform scientists and clinicians about relevant aspects of stemcell derived β-cell transplantation
– To discuss the current hurdles and future challenges to implement this novel β-cell replacement therapy
– To create a networking platform for clinicians and scientists involved in stem cell biology and generation of ATMPs in Europe
Who should attend these new activities?
Medical professionals working in the field of transplantation and diabetes; basic and translational scientists in human islet biology; basic scientists in islet development and stem cell biology; scientists involved in generation of ATMP and regulatory affairs.
Medical professionals working in the field of transplantation and diabetes such as transplant physicians, surgeons and diabetologists. Basic and translational scientists in human islet biology, developmental and stem cell biology. Scientists and clinicians interested in generation of ATMP and regulatory affairs.
Eelco de Koning, Chair EPITA Board
Steve White, Vice-Chair EPITA Board
Helmut Arbogast, EPITA Board Member
Claudia Boesmueller, EPITA Board Member
Marcella Franquesa, ECTORS Board Member
Julie Kerr-Conte, EPITA Board Member
Artur Kwiatkowski, EPITA Board Member
Roger Lehmann, EPITA Board Member
Venue Information
Congresspark igls
Eugenpromenade 2
6080 Igls / Innsbruck, Austria
Travelling Information
Plane
As a member of the global Star Alliance Network, Austrian Airlines guarantees full coordination with other international airlines and timetables for optimum connections worldwide. Innsbruck has its own airport, located about 3 km from the city centre which can be reached either by bus or by taxi. Munich Airport, located some 180 km or a 2-hour drive away, presents a further option for getting to Innsbruck by plane. Direct connections to/from Innsbruck are (depending on winter-/ summer-season): Vienna, Graz, Frankfurt, Hannover, Cologne, Bonn, Berlin, London, Amsterdam, Göteborg, Copenhagen, Oslo and Stavanger. From Vienna, Frankfurt and Munich access to all international airlines. Further information: Airport Innsbruck – www.flughafen-innsbruck.at Airport Munich – www.munich-airport.de Where Igls is situated – www.come-innsbruck.at
Train
Thanks to its central location at the heart of europe (bording 7 countries – Germany, Swizerland, Italy, Hungary, Czech Republic, Slovac Republic, Slovenia, Liechtenstein) Innsbruck is also easily accessible by train. Innsbruck railway station has good Intercity and Eurocity connections to Zurich (approx. 3.5h), Munich (approx. 2h), Vienna (approx. 5h) or Bolzano (approx. 2 h). The main railway station is close to the downtown area (10-min by taxi to congresspark igls).
Car
Innsbruck is easily accessible by car, with an excellent network of roads from all over Europe. You may use the highway exits A12 – Innsbruck Mitte, Ost or West or highway A13 exit Patsch and then towards Igls and congresspark. Salzburg approx. 2-hr drive Vienna approx. 5-hr drive Munich approx. 2-hr drive Zurich approx. 3-hr drive Milan approx. 4-hr drive
Registrations Platform: Closed
